Last reviewed · How we verify

NCT04870099: DWM

Guided Self-help for Common Mental Disorders

Completed NA Results posted Last updated 3 August 2025
What this trial tests

NA trial testing Doing What Matters in Times of Stress: An Illustrated Guide in Bibliotherapy in 141 participants. Completed in 21 May 2022.

Timeline
17 October 2020
Primary endpoint
21 February 2022
21 May 2022

Quick facts

Lead sponsorIndiana University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment141
Start date17 October 2020
Primary completion21 February 2022
Estimated completion21 May 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Indiana University

Who can join

18 and older, any sex, with Bibliotherapy. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

6-week Change in Kessler 6 Psychological Distress Scale (K6) Primary · Change from Baseline to Week 6

Changes in K6 from baseline to Week 6. The K6 is a measure of distress and the measure is scored on a scale of 0 - 24 where higher scores indicate higher distress (i.e., are negative). Thus, lower scores relative to baseline indicate more positive outcomes.

GroupValue95% CI
Guided Self-help-5.68± 3.61
6-week Change in the WHO 5 Well-being Index (WHO-5) Primary · Change from Baseline to Week 6

Changes in WHO-5 from baseline to Week 6. The WHO-5 is a measure of well-being and the measure is scored on a scale of 0 - 100 where higher scores indicate higher satisfaction with life (i.e., are positive). Thus, higher scores relative to baseline indicate more positive outcomes.

GroupValue95% CI
Guided Self-help13.61± 18.20
6-week Change in Emotion Regulation Scale (ERQ) - Reappraisal Subscale Secondary · Change from Baseline to Week 6

Changes in the ERQ Reappraisal subscale from baseline to Week 6. The Reappraisal scale is a measure of regulating emotions by engaging in reappraisal (i.e., changing the one one thinks about an emotion evoking stimuli), widely considered an adaptive strategy. The measured is scored on a 1-7 scale where higher scores indicate greater use of adaptive emotion regulation strategies (i.e., positive). Thus, higher scores relative to baseline indicate more positive outcomes.

GroupValue95% CI
Guided Self-help0.89± 1.10
6-week Change in the Emotion Regulation Scale (ERQ) - Suppression Subscale Secondary · Change from Baseline to Week 6

Changes in the ERQ Suppression Scale from baseline to Week 6. The ERQ Suppression scale is a measure of regulating emotions by engaging in suppression (i.e., trying not to think or feel), which is considered a maldaptive emotion regulation strategy. The measure is scored on a scale of 1 - 7 where higher scores indicate higher use of suppression (i.e., negative). Thus, lower scores relative to baseline indicate more positive outcomes.

GroupValue95% CI
Guided Self-help-0.46± 1.18
3-month Change in Kessler 6 Psychological Distress Scale (K6; 0 - 24) Secondary · Change from Baseline to 3 Months post-treatment

Changes in K6 from baseline to 3 months after the termination of the study. The K6 is a measure of distress and the measure is scored on a scale of 0 - 24 where higher scores indicate higher distress (i.e., negative). Thus, lower scores relative to baseline indicate more positive outcomes.

GroupValue95% CI
Guided Self-help-4.91± 3.85
3-month Change in the WHO 5 Well-being Index (WHO-5) Secondary · Change from Baseline to 3 Months post-treatment

Changes in WHO-5 from baseline to 3 months after the termination of the study. The WHO-5 is a measure of well-being and the measure is scored on a scale of 0 - 100 where higher scores indicate higher satisfaction with life (i.e., are positive). Thus, higher scores relative to baseline indicate more positive outcomes.

GroupValue95% CI
Guided Self-help15.95± 17.32

Adverse events — posted to ClinicalTrials.gov

Time frame: 6-week assessment period. Reporting threshold: 2%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.

Guided Self-help
Serious: 0/141 (0%)
Deaths: 0/141
Other adverse events (2 terms — click to expand)

ReactionSystemGuided Self-help
Study non-responsePsychiatric disorders
Study non-engagementPsychiatric disorders

Data from ClinicalTrials.gov NCT04870099 adverse events section.

Sponsor's own description

Common mental disorders (CMDs) like depression and anxiety account for a large proportion of disability worldwide. Access to effective treatments like cognitive-behavioral therapy (CBT) is limited and has not reduced the public health burden of psychopathology. For patients with mild-moderate CMDs, lower-intensity treatments like guided self-help CBT (GSH-CBT) are effective and more scalable (e.g., via the internet). The advent of social media has opened avenues for dissemination of GSH-CBTs and allows for passive sensing of mood, thinking, behavior, and social networks. We propose to leverage a social media platform used by over a fifth of the United States (Twitter) as a recruitment tool to virtually screen over 150 individuals, recruit N=60 to a 5-week course of GSH-CBT, and extract social media data from individuals engaged in GSH-CBT. Sociodemographic and social media data will be used to predict engagement, outcomes, and processes in GSH-CBT.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Acceptability and Outcomes of Transdiagnostic Guided Self-help Bibliotherapy for Internalizing Disorder Symptoms in Adults: A Fully Remote Nationwide Open Trial.
    Lorenzo-Luaces L, Howard J, De Jesús-Romero R, Peipert A, et al · · 2023 · cited 7× · PMID 36530566 · DOI 10.1007/s10608-022-10338-5
  2. Emotion regulation as a mechanism of change in transdiagnostic low-intensity cognitive behavioral therapy for internalizing distress: Disaggregating within vs. between individual
    De Jesús-Romero R, Starvaggi I, Howard J, Peipert A, et al · · 2022 · DOI 10.31234/osf.io/t6ymw

Verify or expand the search:

Other trials of Doing What Matters in Times of Stress: An Illustrated Guide

Trials testing the same drug.

Other recruiting trials for Bibliotherapy

Currently open trials in the same condition.

Other Indiana University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04870099.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing